Ronnie Das, PhD

Ronnie joined HPL in 2012 after receiving his PhD in Bioengineering from the University of Washington.  Currently, his research objective is to aid pathologists in the early detection and diagnosis of pancreatic cancer by combining 3D imaging (OPTM) and microfluidic technology to noninvasively and nondestructively interrogate core biopsies (CBs) obtained from patients.  Project aims include 1) 3D optical imaging of pancreatic CBs, 2) 3D reconstruction and image processing, 3) exploratory research of whole tissue staining and histopathology, 3) millifluidics device development and 5) novel instrumentation.  The project is interdisciplinary and a collaborative venture between Mechanical and Bioengineering, UW Pathology and private industry.